High-performance liquid chromatographic determination of morphine and its 3- and 6-glucuronide metabolites by two-step solid-phase extraction

Journal of Chromatography B: Biomedical Sciences and Applications

Volumn 742, Issue 1, 2000, Pages 115-123

  Meng, Qing Cheng ^a   Soleded Cepeda, M ^a   Kramer, Tom ^a   Zou, Helen ^a   Matoka, Derek J ^a   Farrar, John ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Morphine; Morphine glucuronides

Indexed keywords

MORPHINE; MORPHINE 3 GLUCURONIDE; MORPHINE 6 GLUCURONIDE;

ACCURACY; ADULT; ARTICLE; CALIBRATION; CONTROLLED STUDY; DRUG DETERMINATION; DRUG METABOLISM; GENETIC POLYMORPHISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SOLID PHASE EXTRACTION; SPECTROFLUOROMETRY; VOLUNTEER;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; MORPHINE; MORPHINE DERIVATIVES; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0034717231     PISSN: 13872273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(00)00146-8     Document Type: Article

References (46)

1. McQuay H.J., Carroll D., C Faura C., Gavaghan D.J., Hand C.W., Moore R.A. Clin. Pharmacol. Ther. 48:1990;236-244.
2. Thompson P.I., Joel S.P., John L., Wedzicha J.A., Maclean M., Slevin M.L. Br. J. Clin. Pharmacol. 40:1995;145-152.
3. Brunk S.F., Delle M. Clin. Pharmacol. Ther. 16:1974;51-57.
4. Labella F.S., Pinsky C., Harlicek V. Brain Res. 174:1979;263-271.
5. Yaksh T.L., Harty G.J., Onofrio B.M. Anesthesiology. 64:1986;590-597.
6. Smith M.T., Watt J.A., Cramond T. Life Sci. 47:1990;579-586.
7. Gong Q.L., Hedner J., Björkman R., Hedner T. Pain. 48:1992;249-255.
8. Gong Q.-L., Hedner T., Hedner J., Björkman R., Nordberg G. Eur. J. Pharmacol. 193:1991;47-56.
9. Shimomura K., Kamata O., Ueki S., Tohuku J. Exp. Med. 105:1991;45-52.
10. Abbott F.V., Palmour R.M. Life Sci. 43:1988;1685-1695.
11. Osborne R.J., Joel S., Slevin M.C. Br. Med. J. 292:1986;1548-1549.
12. Hanna M.H., Peat S.J., Woodham M., Kinbb A., Fung C. Br. J. Anaesthiol. 64:1990;547-550.
13. Wasels R., Belleville F., Paysant P., Nabet P. J. Chromatogr. 489:1989;411-418.
14. Brose W.G., Tanelian D.L., Brodsky J.B., Mark J.B.D., Cousins M.J. Pain. 45:1991;11-15.
15. Lee J.W., Pederson J.E., Moravetz T.L., Dzerk A.M., Mundt A.D., Shepard K.V. J. Pharm. Sci. 80:1991;284-288.
16. Chapman D.J., Joel S.P., Aherne G.W. J. Pharm. Biomed. 12:1994;353-360.
17. Chapman D.J., Cross M.J., Joel S.P., Aherne G.W. Ann. Clin. Biochem. 32:1995;297-302.
18. Loh H.H., Ho I.K., Cho T.M., Lipscomb W. J. Chromatogr. 76:1973;505-508.
19. Wang S.Y., Tham S.Y., Poon M.K. J. Chromatogr. 381:1986;331-341.
20. Leung M.K. Adv. Neuroimmunol. 4:1994;93-103.
21. Wasels R., Belleville F. J. Chromatogr. A. 674:1994;225-234.
22. Fryies B., Dawson M., Mather L.E. J. Chromatogr. B. 693:1997;51-57.
23. Bogusz M.J., Maier R.D., Schiwy-Bochat K.H., Kohls U. J. Chromatogr. B. 683:1996;177-188.
24. Svensson J.-O., Rane A., Säwe J., Sjöqvist F. J. Chromatogr. 230:1982;427-432.
25. Milne R.W., Nation R.L., Reynolds G.D., Somogyi A.A., Crugten J.T.V. J. Chromatogr. 565:1991;457-464.
26. Cari G., Gulati A., Bhat R., Tebbett I.R. J. Chromatogr. 571:1991;263-270.
27. Glare P.A., Walsh T.D., Pippenger C.E. Ther. Drug Monit. 13:1991;226-232.
28. Venn R.F., Michalkiewicz A. J. Chromatogr. 525:1990;379-388.
29. Svensson J.-O. J. Chromatogr. 375:1986;174-178.
30. Wright A.W.E., Watt J.A., Kennedy M., Cramond T., Smith M. Ther. Drug Monit. 16:1994;200-208.
31. Konishi M., Hashimoto H. J. Pharm. Sci. 79:1990;379-383.
32. Joel S.P., Osborne R.J., Slevin M.L. J. Chromatogr. 430:1988;394-399.
33. Nishikawa M., Nakajima K., Igarashi K., Kasuya F., Fukui M., Tsuchihashi H. Jpn. J. Toxicol. Environ. Health. 38:1992;121-126.
34. Pacifici R., Pichini S., Altieri I., Caronna A., Passa A.R., Zuccaro P. J. Chromatogr. B. 664:1995;329-334.
35. Tyrefors N., Hyllbrant B., Ekman L., Johansson M., Långström B. J. Chromatogr. A. 729:1996;279-285.
36. Zheng M., McErlane K.M., Ong M.C. J. Pharm. Biomed. Anal. 16:1998;971-980.
37. Cepeda M.S., Farrar J.T., Roa J.H., Boston R., Meng Q.C., Ruiz F., Carr D.B., Strom B. 9th World Congress on Pain :1999;IASP Press, Vienna.
38. Coulochem II, Operating Manual, 5.2 Potential Required to Effect an Electrochemical Reaction, A. Current/Voltage Curves. May 1992;ESA, Bedford, MA. Rev. 5.
39. Weiss P., Hersey R.M., Dujovne C.A., Bianchine J.R. Clin. Pharmacol. Ther. 10:1969;401-406.
40. Gerhardt G.A., Drebing C.J., Freeman R. Anal. Chem. 58:1986;2879-2883.
41. Cosbey S.H., Craig I., Gill R. J, Chromatogr. B. 669:1995;229-235.
42. Scheurer J., Moore C.M. J. Anal. Toxicol. 16:1992;264.
43. Bogusz M., Erkens M., Maiier R.D. Sachs H. Drogenkontrolle in der Heutigen Gesellschaft. 1995;59-64 Dr. Dieter Helm Verlag, Heppenheim.
44. Bogusz M., Erkens M. Toxichem. 59:1992;2.
45. Olieman C., Maat L., Waliszewski K., Beyerman H.C. J. Chromatogr. 133:1977;382-385.
46. Kubiak E.J., Munson J.W. J. Pharm. Sci. 69:1980;152-156.